Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 75, Issue 5
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical and epidemiological research
Extended report
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
Online download statistics by month:
Online download statistics by month: April 2015 to March 2024
Abstract
Full
Pdf
Apr 2015
721
364
407
May 2015
497
334
271
Jun 2015
149
229
150
Jul 2015
1460
448
418
Aug 2015
350
187
146
Sep 2015
126
182
73
Oct 2015
80
84
36
Nov 2015
90
163
77
Dec 2015
103
123
55
Jan 2016
117
211
98
Feb 2016
137
151
86
Mar 2016
128
164
90
Apr 2016
1733
304
420
May 2016
920
214
247
Jun 2016
321
117
107
Jul 2016
212
86
86
Aug 2016
171
88
74
Sep 2016
146
116
84
Oct 2016
105
124
68
Nov 2016
123
104
45
Dec 2016
93
114
69
Jan 2017
103
149
64
Feb 2017
18
127
44
Mar 2017
9
122
49
Apr 2017
18
197
74
May 2017
13
205
50
Jun 2017
55
163
28
Jul 2017
172
165
47
Aug 2017
152
145
47
Sep 2017
131
121
38
Oct 2017
172
161
51
Nov 2017
155
139
49
Dec 2017
140
135
28
Jan 2018
144
136
35
Feb 2018
170
142
48
Mar 2018
181
159
49
Apr 2018
222
215
30
May 2018
204
186
42
Jun 2018
262
252
65
Jul 2018
215
197
52
Aug 2018
176
164
66
Sep 2018
187
171
78
Oct 2018
245
245
66
Nov 2018
179
169
71
Dec 2018
152
135
72
Jan 2019
257
216
61
Feb 2019
223
174
58
Mar 2019
262
191
75
Apr 2019
271
197
82
May 2019
225
154
38
Jun 2019
153
126
71
Jul 2019
198
162
64
Aug 2019
151
117
42
Sep 2019
108
87
37
Oct 2019
120
105
37
Nov 2019
96
81
32
Dec 2019
265
95
28
Jan 2020
119
93
40
Feb 2020
133
100
38
Mar 2020
95
74
30
Apr 2020
73
49
43
May 2020
81
61
21
Jun 2020
46
28
17
Jul 2020
101
85
28
Aug 2020
61
40
25
Sep 2020
96
72
30
Oct 2020
92
71
43
Nov 2020
103
80
28
Dec 2020
97
84
31
Jan 2021
132
109
40
Feb 2021
118
82
43
Mar 2021
107
70
47
Apr 2021
86
67
27
May 2021
125
83
31
Jun 2021
64
64
34
Jul 2021
92
92
53
Aug 2021
73
71
53
Sep 2021
93
91
29
Oct 2021
111
89
50
Nov 2021
140
106
67
Dec 2021
109
85
35
Jan 2022
128
95
39
Feb 2022
144
111
41
Mar 2022
187
156
32
Apr 2022
225
216
26
May 2022
202
186
44
Jun 2022
145
116
29
Jul 2022
95
79
19
Aug 2022
121
101
22
Sep 2022
99
88
24
Oct 2022
124
96
26
Nov 2022
125
96
37
Dec 2022
74
55
24
Jan 2023
110
104
21
Feb 2023
102
84
15
Mar 2023
88
79
14
Apr 2023
92
77
33
May 2023
80
68
29
Jun 2023
103
82
16
Jul 2023
61
48
29
Aug 2023
60
50
20
Sep 2023
109
93
16
Oct 2023
217
201
19
Nov 2023
257
238
16
Dec 2023
239
211
11
Jan 2024
64
64
31
Feb 2024
155
97
14
Mar 2024
86
75
136
Total
19425
14424
6641
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF